Applied Biomimetic Launches New Ultrafiltration Products

5 February, 2020
For Public Release

Gaithersburg, MD ‐‐ Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, announces two new membrane products to its solution portfolio, with the addition of PS 20,000 and PS 30,000 Dalton molecular weight cut off (MWCO) rated membranes. These membranes are available in spiral-wound configuration across various standard sizes and component configurations.

Commenting on the new products, William Harvey, Vice President: “These two membranes build on our unique formulations, proprietary casting technology, and our new manufacturing facility that was inaugurated in 2019. Our 10,000 Dalton membrane is a workhorse for our customers in the production of a variety of plant protein, dairy protein, enzyme and other valuable molecules. These new 20,000 and 30,000 Dalton membranes are additional tools for our customers to separate, concentrate and purify their high value target molecules.

Our membrane offering will continue to broaden, as requested by our customers, distributors and stakeholders. We have other membranes with unique performance attributes which are advancing through our rigorous development process.”

For product inquiries: sales@appliedbiomimetic.com

About Applied Biomimetic, Inc:

Applied Biomimetic is a leader in the convergence of polymer and protein membrane technology. We have developed a high-performance membrane platform for water, life science, enzyme, food, and dairy separation applications

Our core technology is based on new chemistry and manufacturing methods to achieve highly permeable membrane material with narrow molecular size exclusion cut-off. We are also recognized as a leader in the expression, purification, and production scale-up of porins from biological sources as well as synthesis of various types of polymeric amphiphiles. By adding an active protein layer, the membranes will separate constituents at the ion level. We specialize in block copolymer synthesis and lamellar phases self-assembly. Applied Biomimetic holds global patents for the concept of embedding proteins in a proprietary polymeric membrane structure.

We foresee a number of new innovative applications for our technology platform that may be established at a later stage, e.g. new delivery mechanisms for pharmaceuticals, new coatings for contact lenses, and more effective products for the cosmetics industry.

For more general company information, visit http://www.appliedbiomimetic.com/ or call +1.240.292.1129.